Literature DB >> 17274681

Metoclopramide-induced delayed non-thrombocytopenic purpuric rash.

S Upputuri1, S Prasad.   

Abstract

A 62-year-old man with no drug allergies was admitted for coronary artery bypass grafting. Postoperatively, metoclopramide was commenced for the treatment of gastroparesis. Ten days after the drug was initiated a purpuric rash was noticed on his lower limbs. His platelet count was normal. Infection was excluded and the cause was not obvious. No change was noticed in the condition of rash despite discontinuation of all other medications started in the hospital one at a time. The rash later began to subside upon discontinuation of metoclopramide. A rechallenge was not attempted for ethical reasons. In conclusion, metoclopramide was considered to be the causative agent of this rash as it subsided after the discontinuation of metoclopramide.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17274681     DOI: 10.2165/00044011-200626120-00008

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  7 in total

1.  Delayed-type hypersensitivity rash from paracetamol.

Authors:  R Irion; H Gall; T Werfel; R U Peter
Journal:  Contact Dermatitis       Date:  2000-07       Impact factor: 6.600

2.  Angiitis following procainamide therapy. Case report.

Authors:  D L Dolan
Journal:  Mo Med       Date:  1968-05

3.  [Megakaryocytic thrombopenic purpura caused by metoclopramide].

Authors:  B Nomdedeu; J M Ribera Santasusana; J Sánchez Bisonó; E Montserrat; C Rozman
Journal:  Sangre (Barc)       Date:  1982

4.  A fixed drug eruption due to paracetamol.

Authors:  H T Wilson
Journal:  Br J Dermatol       Date:  1975-02       Impact factor: 9.302

5.  Reversible nonthrombocytopenic palpable purpura associated with metoclopramide.

Authors:  J A Goad
Journal:  Ann Pharmacother       Date:  1999-01       Impact factor: 3.154

6.  [Evaluation of unexpected and toxic effects of omeprazole (Mopral) reported to the regional centers of pharmacovigilance during the first 22 postmarketing months].

Authors:  A Castot; I Bidault; R Dahan; M L Efthymiou
Journal:  Therapie       Date:  1993 Sep-Oct       Impact factor: 2.070

7.  Adverse reactions in the skin from anti-hypertensive drugs.

Authors:  K Thestrup-Pedersen
Journal:  Dan Med Bull       Date:  1987-12
  7 in total
  1 in total

1.  Henoch-Schonlein purpura due to sodium valproate: A case report.

Authors:  Firozeh Hosseini; Mojgan Safari
Journal:  Clin Case Rep       Date:  2022-03-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.